ANTHEMBSEANTHEM BIOSCIENCES LTDMediumNeutral
Announced Mon, 27 Jul · 10:52 IST

Q1 FY27 call: Rs 418 cr revenue, soft quarter on delivery timing shifts

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedInvestor Communications View source PDF

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹769.10
prior close
₹789.35
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.4+0.1+0.7
Up moveDown movePending
AI summary

Q1 FY27 revenue Rs 418 cr (CRDMO Rs 341 cr, Specialty Rs 78 cr). EBITDA Rs 176 cr at 39.6% margin. PAT Rs 120 cr at 27.1% margin. Net cash Rs 1,720 cr. Soft quarter due to customer delivery deferrals to H2. Mgmt confident on full-year growth, 60% order book secured. Added 1 new Big Pharma client, 10 molecules in late phase. Unit 4 Rs 1,200 cr capex by FY28. FY27 capex Rs 700 cr.

Likely market impact

Soft Q1 reflects customer delivery timing, not demand weakness. Management confident on full-year growth with strong order book and Rs 1,720 cr net cash.